Perrin E. Romine

Perrin E. Romine

Hematology | Hematology Oncology | Oncology

21632 Highway 99
Edmonds, WA 98026

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

QIM26-313: Improving Molecular Testing Rates in Advanced Thyroid Cancer Through a Standardized Testing Pathway.

QIM26-313: Improving Molecular Testing Rates in Advanced Thyroid Cancer Through a Standardized Testing Pathway.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 29, 2026

QIM26-313: Improving Molecular Testing Rates in Advanced Thyroid Cancer Through a Standardized Testing Pathway.

QIM26-313: Improving Molecular Testing Rates in Advanced Thyroid Cancer Through a Standardized Testing Pathway.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

Adaptation of a Tailored Lung Cancer Screening Decision Aid for People With HIV.

Adaptation of a Tailored Lung Cancer Screening Decision Aid for People With HIV.

Journal: CHEST pulmonary

Published: October 11, 2024

Lung Cancer Screening in People With HIV: A Mixed-Methods Study of Patient and Provider Perspectives.

Lung Cancer Screening in People With HIV: A Mixed-Methods Study of Patient and Provider Perspectives.

Journal: American journal of preventive medicine

Published: February 09, 2023

Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.

Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.

Journal: JCO oncology practice

Published: February 04, 2022

Improving the efficacy of immunotherapy in small cell lung cancer: Leveraging recent scientific discoveries and tumor-specific antigens.

Improving the efficacy of immunotherapy in small cell lung cancer: Leveraging recent scientific discoveries and tumor-specific antigens.

Journal: Seminars in oncology

Published: November 16, 2021

Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer.

Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer.

Journal: Cureus

Published: October 15, 2021

Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.

Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.

Journal: Oral oncology

Published: July 22, 2021

18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study.

18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study.

Journal: Breast cancer research : BCR

Published: May 24, 2021

Sarcoidosis Presenting as Isolated Anasarca and Hypercalcemia.

Sarcoidosis Presenting as Isolated Anasarca and Hypercalcemia.

Journal: The American journal of medicine

Published: July 14, 2018

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome.

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome.

Journal: BMC cancer

Published: July 13, 2018

Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility.

Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: November 25, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026